In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GlycoDesign Inc.

Division of Inflazyme Pharmaceuticals Inc.
www.glycodesign.com

Latest From GlycoDesign Inc.

Vulnerable Plaque: Medical Device's New Biological Frontier

As interest in vulnerable plaque heats up, medical device companies hope to capitalize on their earl y lead. But as vulnerable plaque shifts therapies from structural to biological, that lead many not last long. The second of a two-part series.
Medical Device Platform Technologies

University of Toronto and the UT Innovations Foundation

Eight years ago, the University of Toronto and the Innovations Foundation instituted a new policy that offered to give up ownership of most technologies to the researchers who invented them, in return for a 25% cut of the researchers' proceeds. The results of the UT's ownership policy and the IF's reorganization have been dramatic; today, UT researchers disclose about 120 inventions a year, roughly two-thirds of them medically related.
BioPharmaceutical Medical Device

Effecting New Antibiotics, Part I

Gone are the days of random screening for new antibiotics. Now, thanks to molecular biology and genomics, start-up companies have a better sense of the mechanisms of infection. The firms think they've found novel ways to interfere with pathogens, including those resistant to current drugs.
BioPharmaceutical
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Inflazyme Pharmaceuticals Inc.
  • Senior Management
  • Michael Thomas , Pres. & CEO
    Brian Fielding, VP, Fin. & CFO
    Patricia Griffin, VP, Bus. Dev.
  • Contact Info
  • GlycoDesign Inc.
    Phone: (416) 593-6027
    480 University Ave.
    Ste. 400
    Toronto, M5G 1V2
    Canada
Advertisement
Advertisement
UsernamePublicRestriction

Register